524606 Stock Overview
Engages in the manufacture and marketing of various branded and generic pharmaceutical formulations in India. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
+ 1 more risk
Beryl Drugs Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹32.30 |
| 52 Week High | ₹46.00 |
| 52 Week Low | ₹19.51 |
| Beta | 0.57 |
| 11 Month Change | -7.71% |
| 3 Month Change | -0.093% |
| 1 Year Change | 59.98% |
| 33 Year Change | 216.36% |
| 5 Year Change | 474.73% |
| Change since IPO | 4,386.11% |
Recent News & Updates
Recent updates
Shareholder Returns
| 524606 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | -3.4% | -0.2% | 0.3% |
| 1Y | 60.0% | 40.5% | 27.3% |
Return vs Industry: 524606 exceeded the Indian Pharmaceuticals industry which returned 40.5% over the past year.
Return vs Market: 524606 exceeded the Indian Market which returned 27.3% over the past year.
Price Volatility
| 524606 volatility | |
|---|---|
| 524606 Average Weekly Movement | 10.8% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in IN Market | 9.2% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: 524606's share price has been volatile over the past 3 months compared to the Indian market.
Volatility Over Time: 524606's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1993 | n/a | Sanjay Sethi | www.beryldrugs.com |
Beryl Drugs Limited engages in the manufacture and marketing of various branded and generic pharmaceutical formulations in India. The company offers bulk drugs, such as I.V. fluids and small volume injectables, as well as veterinary products. It is also involved in the research and development, and contract manufacturing services.
Beryl Drugs Limited Fundamentals Summary
| 524606 fundamental statistics | |
|---|---|
| Market cap | ₹163.82m |
| Earnings (TTM) | ₹3.39m |
| Revenue (TTM) | ₹224.62m |
48.4x
P/E Ratio0.7x
P/S RatioIs 524606 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 524606 income statement (TTM) | |
|---|---|
| Revenue | ₹224.62m |
| Cost of Revenue | ₹127.81m |
| Gross Profit | ₹96.81m |
| Other Expenses | ₹93.42m |
| Earnings | ₹3.39m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.67 |
| Gross Margin | 43.10% |
| Net Profit Margin | 1.51% |
| Debt/Equity Ratio | 48.7% |
How did 524606 perform over the long term?
See historical performance and comparison